Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2009 08:00 ET | Source: Halozyme Therapeutics

Halozyme Therapeutics Presents Positive Pre-Clinical Single Agent Data for PEGPH20

Significant Single Agent Anti-Tumor Activity Observed With PEGPH20 in Tumor Models That Accumulate Hyaluronan Extended Half-Life of PEGPH20 Allows Continued Depletion of ...
January 15, 2009 08:00 ET | Source: Halozyme Therapeutics

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial With Second Biologic

First Patient Dosed With Second Roche Biologic Formulated With Halozyme's Recombinant Enzyme Technology Halozyme to Receive Milestone Payment SAN DIEGO, Jan....
January 08, 2009 08:00 ET | Source: Halozyme Therapeutics

Halozyme to Present At J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 8, 2009 (GLOBE NEWSWIRE) -- Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the...